Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Candel Therapeutics Insider Sold Shares Worth $3,160,783, According to a Recent SEC Filing

Candel Therapeutics Insider Sold Shares Worth $3,160,783, According to a Recent SEC Filing

MT newswireMT newswire2026/09/14 08:25
04:25 AM EDT, 09/14/2026 (MT Newswires) -- Paul Peter Tak, Director, Chief Executive Officer, on September 10, 2026, sold 280,245 shares in Candel Therapeutics (CADL) for $3,160,783. Following the Form 4 filing with the SEC, Tak has control over a total of 113,321 common shares of the company, with 113,321 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1841387/000187390526000002/xslF345X05/ownership.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!